体位性心动过速合并直立性高血压一例_Journal of Epilepsy

Authors：

 杜晓萍 ¹ , 郝卫成 ¹ , 李杨波 ¹ ,  刘玉玺 ²

1. ;
2. ;

Corresponding author：

刘玉玺, Email: liuyuxi2003@163.com

Keywords：

DOI：

10.7507/2096-0247.201600840096

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 杜晓萍, 郝卫成, 李杨波, 刘玉玺. 体位性心动过速合并直立性高血压一例. Journal of Epilepsy, 2016, 2(6): 552-554. doi: 10.7507/2096-0247.201600840096 Copy

1.	张清友, 杜军保.体位性心动过速综合征发病机制研究进展.中华医学杂志, 2009, 89(28):2011-2012.
2.	Kanjwal Y,Kosinski D,Grubb BP. The postural orthostatic tachycardia syndrome:definitions,diagnosis,and management. Pacing Clin Electrophysiol, 2003, 26 (8):1747-1757.
3.	田中英高. めまぃ, 立ちㄑらみ. 小儿科诊, 2003, 66:1928-1934.
4.	Liao Y, ChenS, Liu X, et al. Flow-mediated vasodilation and endothelium function in children with postural orthostatic tachycardia syndrome. Am J Cardiol, 2010, 106 (3):378-382.
5.	Fessel J, Robertson D. Orthostatic hypertension:when pressor reflexes Overcompensate. Nat Clin Pract Nephrol, 2006, 2(8):424-431.
6.	Kario K, Eguchi K, Hoshide S, et al. U-curve relationship between orthostatic blood pressure change and silent cerebrovascular diseasein elderlyhypertensives:orthostatic hypertension as a new cardiovascularrisk factor. J Am Coll Cardiol, 2002, 40(1):133-141.
7.	Raffai G, Meszaros M, Kollai M, et al. Experimental orthostasis elicits sustained hypertension, which can be prevented by sympathetic blockade in the rat. J Cardiovasc Pharmacol, 2005, 45 (4):354-361.
8.	Kario K. Orthostatic hypertension-a new haemodynamic cardiovascular risk factor. Nat Rev Nephrol, 2013, 9(12):726-738.
9.	Yoshinari M, Wakisaka M, Nakamura U, et al. Orthostatic hypertension in patients with type 2 diabetes. Diabetes Care, 2001, 24(10):1783-1786.
10.	张清友, 杜军保, 王喻丽. β-受体阻滞剂联合口服生理盐水治疗儿童体位性心动过速综合征疗效分析. 临床儿科杂志, 2006, 24(5):357-360.
11.	Grubb BP, Karas B, Kosinski D, et al. Preliminary observationson the use of midodrine hydrochloride in the treatment ofrefractory neurocardiogenic syncope. J Interv Card Electrophysiol, 1999, 3(2):139-143.
12.	Lai CC, Fischer PR, Brands CK, et al. Outcomes in adolescentswith postural orthostatic tachycardia syndrome treatedwith midodrine and beta-blockers. Pacing Clin Electrophysiol, 2009, 32(2):234-238.
13.	Cleophas TJ, Grabowsky I, Niemeyer MG, et al. Paradoxical pressor effects of beta-blockers in standing elderly patients with mild hypertension:a beneficial side effect. Circulation, 2002, 105(14):1669-1671.
14.	Eguchi K, Tomizawa H, Ishikawa J, et al. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure. J Cardiovasc Pharmacol, 2007, 49(6):394-400.

1. 张清友, 杜军保.体位性心动过速综合征发病机制研究进展.中华医学杂志, 2009, 89(28):2011-2012.
2. Kanjwal Y,Kosinski D,Grubb BP. The postural orthostatic tachycardia syndrome:definitions,diagnosis,and management. Pacing Clin Electrophysiol, 2003, 26 (8):1747-1757.
3. 田中英高. めまぃ, 立ちㄑらみ. 小儿科诊, 2003, 66:1928-1934.
4. Liao Y, ChenS, Liu X, et al. Flow-mediated vasodilation and endothelium function in children with postural orthostatic tachycardia syndrome. Am J Cardiol, 2010, 106 (3):378-382.
5. Fessel J, Robertson D. Orthostatic hypertension:when pressor reflexes Overcompensate. Nat Clin Pract Nephrol, 2006, 2(8):424-431.
6. Kario K, Eguchi K, Hoshide S, et al. U-curve relationship between orthostatic blood pressure change and silent cerebrovascular diseasein elderlyhypertensives:orthostatic hypertension as a new cardiovascularrisk factor. J Am Coll Cardiol, 2002, 40(1):133-141.
7. Raffai G, Meszaros M, Kollai M, et al. Experimental orthostasis elicits sustained hypertension, which can be prevented by sympathetic blockade in the rat. J Cardiovasc Pharmacol, 2005, 45 (4):354-361.
8. Kario K. Orthostatic hypertension-a new haemodynamic cardiovascular risk factor. Nat Rev Nephrol, 2013, 9(12):726-738.
9. Yoshinari M, Wakisaka M, Nakamura U, et al. Orthostatic hypertension in patients with type 2 diabetes. Diabetes Care, 2001, 24(10):1783-1786.
10. 张清友, 杜军保, 王喻丽. β-受体阻滞剂联合口服生理盐水治疗儿童体位性心动过速综合征疗效分析. 临床儿科杂志, 2006, 24(5):357-360.
11. Grubb BP, Karas B, Kosinski D, et al. Preliminary observationson the use of midodrine hydrochloride in the treatment ofrefractory neurocardiogenic syncope. J Interv Card Electrophysiol, 1999, 3(2):139-143.
12. Lai CC, Fischer PR, Brands CK, et al. Outcomes in adolescentswith postural orthostatic tachycardia syndrome treatedwith midodrine and beta-blockers. Pacing Clin Electrophysiol, 2009, 32(2):234-238.
13. Cleophas TJ, Grabowsky I, Niemeyer MG, et al. Paradoxical pressor effects of beta-blockers in standing elderly patients with mild hypertension:a beneficial side effect. Circulation, 2002, 105(14):1669-1671.
14. Eguchi K, Tomizawa H, Ishikawa J, et al. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure. J Cardiovasc Pharmacol, 2007, 49(6):394-400.

Previous Article
局灶性皮质发育不良的病理机制

Journal of Epilepsy

体位性心动过速合并直立性高血压一例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content